Dr. Jaeckle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Road S
Jacksonville, FL 32224
Summary
- Kurt A. Jaeckle, M.D., is currently Professor of Neurology and Professor of Oncology at the Mayo Clinic Florida in Jacksonville .
Dr. Jaeckle received his MD from Indiana University School of Medicine, Internship in Medicine and Residency in Neurology at Vanderbilt University in Nashville, TN; and Fellowship in Neuro-oncology at Memorial Sloan Kettering Cancer Center. Dr. Jaeckle is Board Certified in Neurology by the ABPN and in Neuro-oncology by the UCNS. He was an Associate Professor of Neurology at the University of Utah Health Sciences Center; Associate Professor and Deputy Chairman of Neurology at the University of Texas MD Anderson Cancer Center; Medical Director of Research for the Atlantic Health System, and Professor of Neurology and Oncology at the Mayo Clinic.
Dr. Jaeckle has served as an investigator on several national and international Phase I-III clinical trials, and has authored multiple peer-reviewed papers involving primary and metastatic brain tumors and neurologic complications of cancer. He has served on committees for the American Academy of Neurology, Society for Neurooncology, the National Institutes of Health, and National Cancer Institute. He served as Director of the Neurooncology Fellowship Program at MD Anderson Cancer Center, and was instrumental in development of the Certification and Accreditation in Neurooncology for the UCNS.
Dr. Jaeckle’s clinical practice and research focuses on targeted treatments, immunotherapy, vaccines, chemotherapy for patients with primary and metastatic CNS neoplasms.
Dr. Jaeckle enjoys spending time with his wife, Bunny Leach-Jaeckle, supporting her efforts as a patient advocate for ASCO, for the Alliance for Clinical Trials in Oncology, and for Mayo Clinic; and, as Director and CEO of the Nicki Leach Foundation, a non-profit organization supporting cancer research involving adolescents and young adults. He is also a luthier, who builds and repairs acoustic and electric guitars.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1981 - 1983
- Vanderbilt University Medical CenterFellowship, Neuromuscular Medicine (Neurology), 1980 - 1981
- Vanderbilt University Medical CenterResidency, Neurology, 1977 - 1981
- Vanderbilt University Medical CenterInternship, Internal Medicine, 1977 - 1978
- Indiana University School of MedicineClass of 1977
Certifications & Licensure
- FL State Medical License 2000 - 2026
- GA State Medical License 2014 - 2025
- NJ State Medical License 2016 - 2019
- KY State Medical License 2014 - 2017
- UT State Medical License 1983 - 2004
- TX State Medical License 1993 - 2002
- American Board of Psychiatry and Neurology Neurology
- United Council of Neurologic SubspecialtiesNeuro-oncology
Clinical Trials
- Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas
- Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas Start of enrollment: 2000 Jun 01
- Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme Start of enrollment: 2002 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 1881 citationsA Randomized Trial of Bevacizumab for Newly Diagnosed GlioblastomaMark R. Gilbert, James J. Dignam, Terri S. Armstrong, Jeffrey S. Wefel, Deborah T. Blumenthal
The New England Journal of Medicine. 2014-02-19 - 51 citationsUptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruptionJohn E. Greenlee, James Burns, John W. Rose, Kurt A. Jaeckle, Susan A. Clawson
Acta Neuropathologica. 1995-04-01 - 721 citationsOutcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical TrialsEric T. Wong, Kenneth R. Hess, Mary Jo Gleason, Kurt A. Jaeckle, Athanassios P. Kyritsis
Journal of Clinical Oncology. 1999-08-01
Journal Articles
- Phase I Study of Pomalidomide and Dexamethasone for relapsed/refractory Primary CNS or Vitreo-Retinal LymphomaLisa M DeAngelis, Han W Tun, David Schiff, Kurt A Jaeckle, Christian Grommes, Patrick B Johnston, Craig B Reeder, Thomas E Witzig, Blood
- Diffuse Midline Gliomas with Subclonal H3F3A K27M Mutation and Mosaic H3.3 K27M Mutant Protein ExpressionKurt Jaeckle, Yaron A Moshel, Arie Perry, David A Solomon, Acta Neuropathologica
Press Mentions
- Finding Joy After Rare Neurologic DiagnosisOctober 14th, 2021
- Dr. Kurt Jaeckle to Lead Phase III Clinical Trial of Novel Drug VAL-083 for Late-Stage GlioblastomaJanuary 10th, 2018
- Risks of Whole Brain Radiation Therapy Added to Radiosurgery Outweigh Benefits for Patients with Limited Brain MetastasesMay 31st, 2015
Professional Memberships
- Member
- Fellow
- Member
- Society for Neuro-oncologyMember
External Links
- Nicki Leach Foundationhttp://www.nickileach.org
- Prism Guitarshttp://www.prismguitars.com
- Atlantic Health Systemhttp://www.atlantichealth.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: